| ［1］ |
Darrigade AS, Legrand A, Andreu N, et al. Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata［J］. Br J Dermatol, 2018,179（2）:534⁃536. doi: 10.1111/bjd.16711.
|
| ［2］ |
Harada K, Irisawa R, Ito T, et al. The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: a case series of seven patients［J］. Br J Dermatol, 2020,183（2）:396⁃397. doi: 10.1111/bjd.18976.
|
| ［3］ |
Penzi LR, Yasuda M, Manatis⁃Lornell A, et al. Hair regrowth in a patient with long⁃standing alopecia totalis and atopic dermatitis treated with dupilumab［J］. JAMA Dermatol, 2018,154（11）:1358⁃1360. doi: 10.1001/jamadermatol.2018.2976.
|
| ［4］ |
McKenzie PL, Castelo⁃Soccio L. Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis［J］. J Am Acad Dermatol, 2021,84（6）:1691⁃1694. doi: 10.1016/j.jaad.2021.01.046.
|
| ［5］ |
Cho SK, Craiglow BG. Dupilumab for the treatment of alopecia areata in children with atopic dermatitis［J］. JAAD Case Rep, 2021,16:82⁃85. doi: 10.1016/j.jdcr.2021.07.015.
|
| ［6］ |
Guttman⁃Yassky E, Renert⁃Yuval Y, Bares J, et al. Phase 2a randomized clinical trial of dupilumab （anti⁃IL⁃4Rα） for alopecia areata patients［J］. Allergy, 2022,77（3）:897⁃906. doi: 10.1111/all.15071.
|
